News


All News

Epidemiology of BCC

Basal cell carcinoma (BCC) is the most common cancer in the world, with the overall incidence significantly rising across the globe by about 3 to 10% annually.

Ongoing research is trying to identify strategies for overcoming resistance of advanced basal cell carcinoma to targeted therapy with a Hedgehog inhibitor. High level evidence to support adjuvant radiotherapy for high-risk non-melanoma skin cancers is lacking, but certain patients warrant evaluation by a multidisciplinary tumor board and treatment with adjuvant radiotherapy based on their risk for recurrence.

Advances in research have led to the emergence of medical therapies for BCCs; more research is needed to develop systemic therapies to treat SCCs.

In today’s litigious environment, asset protection should be part of physicians’ financial plans. Doctors should educate themselves and consider getting expert advice.

From single devices that perform a spectrum of rejuvenation procedures, to older devices that are re-emerging, to new combinations using tried-and-true technologies, dermatologists are at the forefront of what’s new and exciting in facial rejuvenation. Learn more.

Herpes is everywhere

Human herpes viruses are ubiquitous and they should be kept in mind for atypical presentations in immunocompromised hosts.

In part three of our discussion about pediatric dermatology, Kelly Cordoro, M.D., associate professor of dermatology and pediatrics at the University of California in San Francisco, discusses screening labs, avoiding complacency, and the ABCDEs of melanoma with Dermatology Times editorial advisor, Elaine Siegfried, M.D.

A drug approved for treating psoriasis and psoriatic arthritis also appears to be effective in spurring hair growth. Learn more.

Nearly half of rosacea patients thought they had acne before being diagnosed. Learn how to explain the difference between rosacea and acne to patients and help them get the care they need.

The Hispanic population isn’t just skin of color; it’s skin of different colors. Dermatologists treating Hispanic patients need to understand the diversity and disparities that exist in this fast-growing U.S. population.

Many patients and physicians have the misconception that the Hispanic population is not prone to skin cancer. As a result, these patients are not being diagnosed early.

We finally have effective interventions that address the root cause of cellulite (fibrous tethers). Now, patient education and selection becomes paramount. Long horizontal lines and the infragluteal cleft or bulge, the so-called “banana-roll” cannot be corrected with these interventions. Prior to performing cellulite procedures we must impart this knowledge to our patients to ensure realistic expectations.

Securing a patent requires time, money and a thorough understanding of where your product fits among existing intellectual property, experts say. Other tools for protecting intellectual property include copyrights, trademarks and proprietary information and processes.

There are financial, academic, and altruistic benefits of participating in clinical research. These are some considerations if you'd like to incorporate a research arm into your practice.

If someone wants a certain type of lifestyle, he must do what’s necessary to attain that goal. I don’t think it matters if dermatologists practice as soloists or group members.

In part two of our discussion, Kelly Cordoro, M.D., associate professor of dermatology and pediatrics at the University of California in San Francisco, discusses environmental and microbial triggers and when to choose systemic therapies with Dermatology Times editorial advisor, Elaine Siegfried, M.D.